Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity

Details for Australian Patent Application No. 2004260606 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Unger, Thomas; Kauschke, Stefan; Mark, Michael; Schupp, Michael; Kintscher, Ulrich

Agent Davies Collison Cave

Pub. Number AU-B-2004260606

PCT Pub. Number WO2005/011680

Priority 10346260.0 06.10.03 DE; 10335027.6 31.07.03 DE; 10356815.8 05.12.03 DE

Filing date 24 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 9 December 2010

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4184 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011680 Priority application(s): WO2005/011680

9 December 2010 Application Accepted

  Published as AU-B-2004260606

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260608-Flocculating agent, method for the production and use thereof

2004260595-Method and device for improving the permeability of the human skin